The Clinical Significance of Pathogen Loads and Macrolide Resistance Levels for Macrolide-Resistant Mycoplasma pneumoniae Pneumonia in Children

Maodong Leng,Lu Xu,Zhen Dong,Junmei Yang

DOI: https://doi.org/10.2147/jir.s491981

IF: 4.5

2024-10-16

Journal of Inflammation Research

Abstract:Maodong Leng, 1 Lu Xu, 1 Zhen Dong, 2 Junmei Yang 1 1 Department of Clinical Laboratory, Zhengzhou Key Laboratory of Children's Infection and Immunity, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital, Zhengzhou, Henan, People's Republic of China; 2 Pediatric Internal Medicine Department, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital, Zhengzhou, Henan, People's Republic of China Correspondence: Junmei Yang, Department of Clinical Laboratory, Zhengzhou Key Laboratory of Children's Infection and Immunity, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital, No. 33 of Longhu Outer Street, Zhengzhou East District, Zhengzhou, Henan Province, People's Republic of China, Email Objective: Mycoplasma pneumoniae ( M. pneumoniae ) pneumonia presses a serious threat on children's health. This study was aimed to investigate the clinical significance of pathogen loads and macrolide resistance levels for macrolide-resistant M. pneumoniae (MRMP)-induced pneumonia in children. Methods: Serum levels of inflammatory markers including lactic dehydrogenase (LDH), D-dimer, C-reactive protein (CRP) were tested. RT‒PCR was used for the detection of M. pneumoniae infection and the macrolide resistance levels. The patients were classified into high pathogen load and low pathogen load groups based on the Ct values of the p1 gene, and high macrolide resistance level and low macrolide resistance level groups based on the relative levels of macrolide resistance associated mutations to that of the p1 gene. The rates of alternative antibiotic use and hospitalization days were recorded, and the leukocyte counts were tested. Results: The rates of elevated inflammatory markers from high to low were LDH, CRP and D-dimer. The Ct values of the p1 gene ranged from 19 to 35, and patients with higher pathogen loads had greater rates of alternative antibiotic use; higher levels of LDH, D-dimer, CRP and neutrophil counts (NEUT); and longer hospitalization durations. The range of the macrolide resistance levels was 0.31– 2.11, and the rates of alternative antibiotic use, NEUT, CRP and D-dimer levels were higher in patients with higher macrolide resistance levels. Conclusion: LDH was a more frequently elevated serum inflammatory marker than D-dimer and CRP, and the pathogen load and macrolide resistance levels possessed important clinical significance for MRMP-induced pneumonia in children. Keywords: Mycoplasma pneumoniae pneumonia, children, inflammation, macrolide resistance levels, pathogen load Mycoplasma pneumoniae ( M. pneumoniae ) is an important pathogen that can cause pneumonia, accounting for 10–40% of community-acquired pneumonia cases. 1 Due to the self-limited nature of M. pneumoniae infection, the symptoms are often mild, but it can cause severe and refractory pneumonia in children, which places a heavy burden on children's health and even endangers lives. 2,3 Macrolide antibiotics are regarded as the first-line treatment for M. pneumoniae infections in children. 4 But due to the widespread and inappropriate use of macrolides, macrolide resistance has developed rapidly among M. pneumoniae strains, which has increased the morbidity of refractory pneumonia in children. 5–9 However, effective quinolones and tetracyclines for M. pneumoniae infection may have side effects on children. As a result, alternative antibiotics will be selected for the treatment of macrolide-resistant M. pneumoniae (MRMP)-induced pneumonia patients by pediatric clinicians after full considerations of the disease severity, benefits of alternative antibiotics and possible side effects. 10,11 Real-time PCR (RT‒PCR) for the detection of DNA from M. pneumoniae strains has been used for the detection of infections, which has advantages including being fast, accurate and reflecting the pathogen load in the body. 4 The protein encoded by the p1 gene was identified as the major determinant for M. pneumoniae adhesion. 12 RT‒PCR targeting the p1 gene can be used for the detection of M. pneumoniae infection. The macrolide resistance of M. pneumoniae is attributed to single-point mutations in region V of the 23S rRNA gene, including mutations at sites 2063, 2064, 2611, 2061, 2617 and 2067, among which A2063G and A2064G are the dominant mutations and other mutations rarely exist. 13–15 RT‒PCR targeting the A2063G and A2064G mutations can be applied for the detection of the macr -Abstract Truncated-

immunology